chr8-52656213-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014781.5(RB1CC1):c.3616G>A(p.Glu1206Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000738 in 1,613,448 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014781.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RB1CC1 | NM_014781.5 | c.3616G>A | p.Glu1206Lys | missense_variant | 15/24 | ENST00000025008.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RB1CC1 | ENST00000025008.10 | c.3616G>A | p.Glu1206Lys | missense_variant | 15/24 | 1 | NM_014781.5 | P4 | |
RB1CC1 | ENST00000435644.6 | c.3616G>A | p.Glu1206Lys | missense_variant | 15/24 | 1 | A1 | ||
RB1CC1 | ENST00000521611.1 | n.385+30733G>A | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152078Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250684Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135504
GnomAD4 exome AF: 0.0000773 AC: 113AN: 1461252Hom.: 1 Cov.: 32 AF XY: 0.0000770 AC XY: 56AN XY: 726922
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74398
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2021 | The c.3616G>A (p.E1206K) alteration is located in exon 15 (coding exon 13) of the RB1CC1 gene. This alteration results from a G to A substitution at nucleotide position 3616, causing the glutamic acid (E) at amino acid position 1206 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at